Observational studyAmerican journal of respiratory and critical care medicine2021
Rapid Improvement after Starting Elexacaftor-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease.
Pierre-Régis Burgel et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
110 papers cite itlatest 60 shown
this paperpooled ittrialcites it